Catalonia gives legal backing to trained AED (automatic external defibrillators) users:
This article was originally published in Clinica
The Spanish region of Catalonia is drafting new legislation to give legal backing to trained non-medical personnel who use automatic external defibrillators (AEDs) provided in public places. The relevant training programme will be carried out by the regional government's health studies institute (IES). The decree could be implemented within one-and-a-half months, coinciding with the April launch of a Pta60 million ($350,000) regional project to install AEDs in 50 sports centres throughout Catalonia. The budget for the programme includes the cost of the training. Separately, Galicia will become the third Spanish region to implement a programme to provide AEDs in public places.
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.